Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 December 2023 | Story Anthony Mthembu | Photo SUPPLIED
Albertus Engelbrecht
Albertus Engelbrecht: Lecturer in Singing and Coordinator of Vocal Studies at the Odeion School of Music.

The University of the Free State (UFS) is gearing up to honour a new group of graduates during the upcoming graduation ceremonies on 7-8 December 2023. Among the distinguished individuals set to grace the stage is Albertus Engelbrecht, Coordinator of Vocal Studies at the Odeion School of Music and an internationally recognised opera singer with a career spanning over two decades.

Engelbrecht has achieved a significant milestone, completing his PhD thesis titled “The Journey of a Versatile Singer”. On 7 December 2023, he will formally receive his qualification, marking the culmination of a seven-year academic journey. Reflecting on this achievement, Engelbrecht expressed his relief, stating, “It’s all still so surreal, but I think that the moment I walk onto that stage, then, will it only sink in.’’  

The journey of a versatile singer

His thesis is an auto-ethnographic study that delves into the preparation and performance of five different styles and genres of Western art music. This unique approach includes a practical component, as he actively participated in five different concerts or performances, ultimately contributing to his research. He shared his motivation, stating, ‘’I was investigating how it would be possible to sing different kinds of Western art music styles and genres. The idea came from my professional experience, where I found that to become a successful opera and concert singer, it’s better for one to be able to do different styles and genres.’’  

Looking ahead, Engelbrecht envisions his research making a meaningful impact on the development of emerging singers. He aspires to shape the future of vocal education, stating, “I hope that my contribution leads to new knowledge not only for singers but for their teachers and vocal coaches. This is so that they can approach music in the way it is written, and to find ways which make the music speak the best way it can. In this way, singers can be more versatile.’’  

Future plans

Post-graduation, Engelbrecht has ambitious plans to further his growth within the industry. Expressing his goals, he said, ‘’I would like to grow not just as a performing artist but as a researcher too.” Currently collaborating with his former supervisor on a research project focusing on performance analysis, Engelbrecht aims to delve deeper into the research aspect of his profession. Additionally, as a Lecturer of Singing at the UFS, he looks forward to engaging in more performing projects with his students.

In recognition of Albertus Engelbrecht’s remarkable achievement, the UFS community congratulates him on this significant milestone. His dedication to the field of vocal studies and commitment to fostering versatility in music is truly commendable. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept